These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15520661)

  • 21. Drug addiction: the neurobiology of disrupted self-control.
    Baler RD; Volkow ND
    Trends Mol Med; 2006 Dec; 12(12):559-66. PubMed ID: 17070107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European Association of Addiction Therapy - Inaugural Conference.
    Mucke HA
    IDrugs; 2005 Oct; 8(10):816-7. PubMed ID: 16254800
    [No Abstract]   [Full Text] [Related]  

  • 23. Awakening from addiction the Mâori way.
    Hughes H
    Nurs N Z; 2008 May; 14(5):18-9. PubMed ID: 18610917
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.
    Brodie JD; Figueroa E; Laska EM; Dewey SL
    Synapse; 2005 Feb; 55(2):122-5. PubMed ID: 15543630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinesterase inhibitors might alleviate methamphetamine-induced delusions, hallucinations and cognitive impairment, while reducing craving and addiction.
    Alisky JM
    World J Biol Psychiatry; 2006; 7(4):269. PubMed ID: 17071550
    [No Abstract]   [Full Text] [Related]  

  • 26. Journeys from addiction to recovery.
    Hansen M; Ganley B; Carlucci C
    Res Theory Nurs Pract; 2008; 22(4):256-72. PubMed ID: 19093663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and addiction: common neurological mechanisms and drug development.
    Rapaka R; Schnur P; Shurtleff D
    Physiol Behav; 2008 Sep; 95(1-2):2-9. PubMed ID: 18571681
    [No Abstract]   [Full Text] [Related]  

  • 28. Addiction and chronic pain: diagnostic and treatment dilemmas.
    Modesto-Lowe V; Brooks D; Freedman K; Hargus E
    Conn Med; 2007 Mar; 71(3):139-44. PubMed ID: 17405395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How do we determine which drug-induced neuroplastic changes are important?
    Kalivas PW
    Nat Neurosci; 2005 Nov; 8(11):1440-1. PubMed ID: 16251984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
    Kellogg SH; Burns M; Coleman P; Stitzer M; Wale JB; Kreek MJ
    J Subst Abuse Treat; 2005 Jan; 28(1):57-65. PubMed ID: 15723733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease processes. Chemical addiction is too a disease.
    Neil RN
    J Kans Med Soc; 1978 Nov; 79(11):608-10. PubMed ID: 712184
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic management of relapse prevention in addictive disorders.
    Sofuoglu M; Kosten TR
    Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ecological Assessment of Substance-abuse Experiences (EASE): findings from a new instrument development pilot study.
    Matto HC; Miller K; Spera C
    Addict Behav; 2005 Aug; 30(7):1281-9. PubMed ID: 16022926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction.
    Müller CP; Carey RJ
    Trends Pharmacol Sci; 2006 Sep; 27(9):455-8. PubMed ID: 16876260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs.
    Saxon AJ; McCarty D
    Pharmacol Ther; 2005 Oct; 108(1):119-28. PubMed ID: 16055196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.
    Kirby KC; Benishek LA; Dugosh KL; Kerwin ME
    Drug Alcohol Depend; 2006 Oct; 85(1):19-27. PubMed ID: 16650657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Addicted patients: do not distribute street drugs: do treat with registered psychoactive medication].
    De Jong CA
    Ned Tijdschr Geneeskd; 2007 Sep; 151(36):1970-2. PubMed ID: 17953168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How can even economists call addiction rational?
    Ferguson BS
    Subst Use Misuse; 2006; 41(4):423-6. PubMed ID: 16522556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The business of addiction treatment: A research agenda.
    Kimberly JR; McLellan AT
    J Subst Abuse Treat; 2006 Oct; 31(3):213-9. PubMed ID: 16996384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.